17397547|t|Regulatory network of inflammation downstream of proteinase-activated receptors.
17397547|a|BACKGROUND: Protease-activated receptors (PAR) are present in the urinary bladder, and their expression is altered in response to inflammation. PARs are a unique class of G protein-coupled that carry their own ligands, which remain cryptic until unmasked by proteolytic cleavage. Although the canonical signal transduction pathway downstream of PAR activation and coupling with various G proteins is known and leads to the rapid transcription of genes involved in inflammation, the effect of PAR activation on the downstream transcriptome is unknown. We have shown that intravesical administration of PAR-activating peptides leads to an inflammatory reaction characterized by edema and granulocyte infiltration. Moreover, the inflammatory response to intravesical instillation of known pro-inflammatory stimuli such as E. coli lipopolysaccharide (LPS), substance P (SP), and antigen was strongly attenuated by PAR1- and to a lesser extent by PAR2-deficiency. RESULTS: Here, cDNA array experiments determined inflammatory genes whose expression is dependent on PAR1 activation. For this purpose, we compared the alteration in gene expression in wild type and PAR1-/- mice induced by classical pro-inflammatory stimuli (LPS, SP, and antigen). 75 transcripts were considered to be dependent on PAR-1 activation and further annotated in silico by Ingenuity Pathways Analysis (IPA) and gene ontology (GO). Selected transcripts were target validated by quantitative PCR (Q-PCR). Among PAR1-dependent transcripts, the following have been implicated in the inflammatory process: b2m, ccl7, cd200, cd63, cdbpd, cfl1, dusp1, fkbp1a, fth1, hspb1, marcksl1, mmp2, myo5a, nfkbia, pax1, plaur, ppia, ptpn1, ptprcap, s100a10, sim2, and tnfaip2. However, a balanced response to signals of injury requires a transient cellular activation of a panel of genes together with inhibitory systems that temper the overwhelming inflammation. In this context, the activation of genes such as dusp1 and nfkbia seems to counter-balance the inflammatory response to PAR activation by limiting prolonged activation of p38 MAPK and increased cytokine production. In contrast, transcripts such as arf6 and dcnt1 that are involved in the mechanism of PAR re-sensitization would tend to perpetuate the inflammatory reaction in response to common pro-inflammatory stimuli. CONCLUSION: The combination of cDNA array results and genomic networks reveals an overriding participation of PAR1 in bladder inflammation, provides a working model for the involvement of downstream signaling, and evokes testable hypotheses regarding the transcriptome downstream of PAR1 activation. It remains to be determined whether or not mechanisms targeting PAR1 gene silencing or PAR1 blockade will ameliorate the clinical manifestation of cystitis.
17397547	22	34	inflammation	DiseaseOrPhenotypicFeature	D007249
17397547	49	79	proteinase-activated receptors	GeneOrGeneProduct	14062,14063
17397547	93	121	Protease-activated receptors	GeneOrGeneProduct	14062,14063
17397547	123	126	PAR	GeneOrGeneProduct	14062,14063
17397547	211	223	inflammation	DiseaseOrPhenotypicFeature	D007249
17397547	225	229	PARs	GeneOrGeneProduct	14062,14063
17397547	426	429	PAR	GeneOrGeneProduct	14062,14063
17397547	545	557	inflammation	DiseaseOrPhenotypicFeature	D007249
17397547	573	576	PAR	GeneOrGeneProduct	14062,14063
17397547	682	685	PAR	GeneOrGeneProduct	14062,14063
17397547	718	730	inflammatory	DiseaseOrPhenotypicFeature	D007249
17397547	757	762	edema	DiseaseOrPhenotypicFeature	D004487
17397547	807	819	inflammatory	DiseaseOrPhenotypicFeature	D007249
17397547	871	883	inflammatory	DiseaseOrPhenotypicFeature	D007249
17397547	900	907	E. coli	OrganismTaxon	562
17397547	908	926	lipopolysaccharide	ChemicalEntity	D008070
17397547	928	931	LPS	ChemicalEntity	D008070
17397547	934	945	substance P	ChemicalEntity	D013373
17397547	947	949	SP	ChemicalEntity	D013373
17397547	991	995	PAR1	GeneOrGeneProduct	14062
17397547	1023	1027	PAR2	GeneOrGeneProduct	14063
17397547	1089	1101	inflammatory	DiseaseOrPhenotypicFeature	D007249
17397547	1141	1145	PAR1	GeneOrGeneProduct	14062
17397547	1239	1243	PAR1	GeneOrGeneProduct	14062
17397547	1247	1251	mice	OrganismTaxon	10090
17397547	1277	1289	inflammatory	DiseaseOrPhenotypicFeature	D007249
17397547	1299	1302	LPS	ChemicalEntity	D008070
17397547	1304	1306	SP	ChemicalEntity	D013373
17397547	1372	1377	PAR-1	GeneOrGeneProduct	14062
17397547	1560	1564	PAR1	GeneOrGeneProduct	14062
17397547	1630	1642	inflammatory	DiseaseOrPhenotypicFeature	D007249
17397547	1652	1655	b2m	GeneOrGeneProduct	12010
17397547	1657	1661	ccl7	GeneOrGeneProduct	20306
17397547	1663	1668	cd200	GeneOrGeneProduct	17470
17397547	1670	1674	cd63	GeneOrGeneProduct	12512
17397547	1676	1681	cdbpd	GeneOrGeneProduct	-
17397547	1683	1687	cfl1	GeneOrGeneProduct	12631
17397547	1689	1694	dusp1	GeneOrGeneProduct	19252
17397547	1696	1702	fkbp1a	GeneOrGeneProduct	14225
17397547	1704	1708	fth1	GeneOrGeneProduct	14319
17397547	1710	1715	hspb1	GeneOrGeneProduct	15507
17397547	1717	1725	marcksl1	GeneOrGeneProduct	17357
17397547	1727	1731	mmp2	GeneOrGeneProduct	17390
17397547	1733	1738	myo5a	GeneOrGeneProduct	17918
17397547	1740	1746	nfkbia	GeneOrGeneProduct	18035
17397547	1748	1752	pax1	GeneOrGeneProduct	18503
17397547	1754	1759	plaur	GeneOrGeneProduct	18793
17397547	1761	1765	ppia	GeneOrGeneProduct	268373
17397547	1767	1772	ptpn1	GeneOrGeneProduct	19246
17397547	1774	1781	ptprcap	GeneOrGeneProduct	19265
17397547	1783	1790	s100a10	GeneOrGeneProduct	20194
17397547	1792	1796	sim2	GeneOrGeneProduct	20465
17397547	1802	1809	tnfaip2	GeneOrGeneProduct	21928
17397547	1984	1996	inflammation	DiseaseOrPhenotypicFeature	D007249
17397547	2047	2052	dusp1	GeneOrGeneProduct	19252
17397547	2057	2063	nfkbia	GeneOrGeneProduct	18035
17397547	2093	2105	inflammatory	DiseaseOrPhenotypicFeature	D007249
17397547	2118	2121	PAR	GeneOrGeneProduct	14062,14063
17397547	2169	2177	p38 MAPK	GeneOrGeneProduct	26416
17397547	2246	2250	arf6	GeneOrGeneProduct	11845
17397547	2255	2260	dcnt1	GeneOrGeneProduct	13426
17397547	2299	2302	PAR	GeneOrGeneProduct	14062,14063
17397547	2349	2361	inflammatory	DiseaseOrPhenotypicFeature	D007249
17397547	2397	2409	inflammatory	DiseaseOrPhenotypicFeature	D007249
17397547	2529	2533	PAR1	GeneOrGeneProduct	14062
17397547	2537	2557	bladder inflammation	DiseaseOrPhenotypicFeature	D003556
17397547	2702	2706	PAR1	GeneOrGeneProduct	14062
17397547	2783	2787	PAR1	GeneOrGeneProduct	14062
17397547	2806	2810	PAR1	GeneOrGeneProduct	14062
17397547	2866	2874	cystitis	DiseaseOrPhenotypicFeature	D003556
17397547	Association	13426	14063	Novel
17397547	Association	13426	14062	Novel
17397547	Association	11845	14063	Novel
17397547	Association	11845	14062	Novel
17397547	Association	18035	26416	Novel
17397547	Association	18035	14063	Novel
17397547	Association	19252	26416	Novel
17397547	Association	19252	14063	Novel
17397547	Association	14063	D004487	No
17397547	Association	14063	26416	Novel
17397547	Positive_Correlation	14063	D013373	Novel
17397547	Positive_Correlation	14063	D008070	Novel
17397547	Association	14062	D004487	No
17397547	Association	14062	D003556	Novel
17397547	Association	14062	26416	Novel
17397547	Association	14062	21928	Novel
17397547	Association	14062	20465	Novel
17397547	Association	14062	20194	Novel
17397547	Association	14062	19265	Novel
17397547	Association	14062	19246	Novel
17397547	Association	14062	268373	Novel
17397547	Association	14062	18793	Novel
17397547	Association	14062	18503	Novel
17397547	Association	14062	18035	Novel
17397547	Association	14062	17918	Novel
17397547	Association	14062	17390	Novel
17397547	Association	14062	17357	Novel
17397547	Association	14062	15507	Novel
17397547	Association	14062	14319	Novel
17397547	Association	14062	14225	Novel
17397547	Association	14062	19252	Novel
17397547	Association	14062	12631	Novel
17397547	Association	14062	12512	Novel
17397547	Association	14062	17470	Novel
17397547	Association	14062	20306	Novel
17397547	Association	14062	12010	Novel
17397547	Positive_Correlation	14062	D013373	Novel
17397547	Positive_Correlation	14062	D008070	Novel
17397547	Association	D007249	13426	Novel
17397547	Association	D007249	11845	Novel
17397547	Association	D007249	26416	Novel
17397547	Association	D007249	21928	Novel
17397547	Association	D007249	20465	Novel
17397547	Association	D007249	20194	Novel
17397547	Association	D007249	19265	Novel
17397547	Association	D007249	19246	Novel
17397547	Association	D007249	268373	Novel
17397547	Association	D007249	18793	Novel
17397547	Association	D007249	18503	Novel
17397547	Association	D007249	18035	Novel
17397547	Association	D007249	17918	Novel
17397547	Association	D007249	17390	Novel
17397547	Association	D007249	17357	Novel
17397547	Association	D007249	15507	Novel
17397547	Association	D007249	14319	Novel
17397547	Association	D007249	14225	Novel
17397547	Association	D007249	19252	Novel
17397547	Association	D007249	12631	Novel
17397547	Association	D007249	12512	Novel
17397547	Association	D007249	17470	Novel
17397547	Association	D007249	20306	Novel
17397547	Association	D007249	12010	Novel
17397547	Positive_Correlation	D007249	D013373	No
17397547	Positive_Correlation	D007249	D008070	No
17397547	Association	D007249	14063	Novel
17397547	Association	D007249	14062	Novel